# St. Vincent's Medical Center/BB – FDA Inspection, Oct 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/st-vincents-medical-centerbb/b9441ab0-ad6f-401c-934c-56a017da2c29
Source feed: FDA_Inspections

> FDA inspection 1110330 of St. Vincent's Medical Center/BB, October 21, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1110330
- Company Name: St. Vincent's Medical Center/BB
- Inspection Date: 2019-10-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 999091 - 2017-01-31
- FDA Inspection 918717 - 2015-03-16
- FDA Inspection 828450 - 2013-04-23
- FDA Inspection 720571 - 2011-04-20
- [FDA Inspection 594950 - 2009-07-07](https://www.keypedia.com/records/fda_inspections/st-vincents-medical-centerbb/1733bc61-83c3-4c53-9f34-8d392f9de55b)

Company: https://www.keypedia.com/companies/st-vincents-medical-centerbb/2c43faa2-fec3-4495-be76-b542b4947f1a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d